Is One Cycle of Neoadjuvant Pembro OK in dMMR Colon Cancer?

Transforming Colon Cancer Treatment: The Impact of Pembrolizumab Recent groundbreaking findings from the RESET-C study have shown promising results for patients with deficient mismatch repair (dMMR) colon cancer, sparking significant interest in the medical community. The study revealed that a single cycle of neoadjuvant pembrolizumab might be enough to achieve a pathologic complete response in … Read more

Metronomic chemotherapy offers hope for children with neuroblastoma

A Ray of Hope for Children: The Future of Metronomic Chemotherapy in Neuroblastoma Treatment Neuroblastoma, the most common extracranial solid tumor in children, presents a daunting challenge due to its advanced diagnosis in nearly 50% of cases. Despite treatment advancements, survival rates for high-risk and relapsed cases remain disheartening. In resource-limited settings, alternative therapies are … Read more